Literature DB >> 29775405

The Mouse Heart Attack Research Tool 1.0 database.

Kristine Y DeLeon-Pennell1,2, Rugmani Padmanabhan Iyer1, Yonggang Ma1, Andriy Yabluchanskiy3, Rogelio Zamilpa4, Ying Ann Chiao5, Presley L Cannon1, Abdullah Kaplan1, Courtney A Cates1, Elizabeth R Flynn1, Ganesh V Halade6, Lisandra E de Castro Brás7, Merry L Lindsey1,2.   

Abstract

The generation of big data has enabled systems-level dissections into the mechanisms of cardiovascular pathology. Integration of genetic, proteomic, and pathophysiological variables across platforms and laboratories fosters discoveries through multidisciplinary investigations and minimizes unnecessary redundancy in research efforts. The Mouse Heart Attack Research Tool (mHART) consolidates a large data set of over 10 yr of experiments from a single laboratory for cardiovascular investigators to generate novel hypotheses and identify new predictive markers of progressive left ventricular remodeling after myocardial infarction (MI) in mice. We designed the mHART REDCap database using our own data to integrate cardiovascular community participation. We generated physiological, biochemical, cellular, and proteomic outputs from plasma and left ventricles obtained from post-MI and no-MI (naïve) control groups. We included both male and female mice ranging in age from 3 to 36 mo old. After variable collection, data underwent quality assessment for data curation (e.g., eliminate technical errors, check for completeness, remove duplicates, and define terms). Currently, mHART 1.0 contains >888,000 data points and includes results from >2,100 unique mice. Database performance was tested, and an example is provided to illustrate database utility. This report explains how the first version of the mHART database was established and provides researchers with a standard framework to aid in the integration of their data into our database or in the development of a similar database. NEW & NOTEWORTHY The Mouse Heart Attack Research Tool combines >888,000 cardiovascular data points from >2,100 mice. We provide this large data set as a REDCap database to generate novel hypotheses and identify new predictive markers of adverse left ventricular remodeling following myocardial infarction in mice and provide examples of use. The Mouse Heart Attack Research Tool is the first database of this size that integrates data sets across platforms that include genomic, proteomic, histological, and physiological data.

Entities:  

Keywords:  big data; bioinformatics; cardiovascular disease; myocardial infarction; proteomics

Mesh:

Year:  2018        PMID: 29775405      PMCID: PMC6172643          DOI: 10.1152/ajpheart.00172.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  49 in total

1.  Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction.

Authors:  Andriy Yabluchanskiy; Yonggang Ma; Ying Ann Chiao; Elizabeth F Lopez; Andrew P Voorhees; Hiroe Toba; Michael E Hall; Hai-Chao Han; Merry L Lindsey; Yu-Fang Jin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-21       Impact factor: 4.733

2.  Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction.

Authors:  Rogelio Zamilpa; Elizabeth F Lopez; Ying Ann Chiao; Qiuxia Dai; Gladys P Escobar; Kevin Hakala; Susan T Weintraub; Merry L Lindsey
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

3.  Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Nicolle L Patterson; Manishabrata Bhowmick; Elizabeth R Flynn; Majdouline Asher; Presley L Cannon; Kristine Y Deleon-Pennell; Gregg B Fields; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2016-10-13       Impact factor: 5.000

4.  Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis.

Authors:  Hiroe Toba; Presley L Cannon; Andriy Yabluchanskiy; Rugmani Padmanabhan Iyer; Jeanine D'Armiento; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-23       Impact factor: 4.733

5.  Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging.

Authors:  Yonggang Ma; Ying Ann Chiao; Jianhua Zhang; Anne M Manicone; Yu-Fang Jin; Merry L Lindsey
Journal:  Microsc Microanal       Date:  2011-12-08       Impact factor: 4.127

6.  Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Fouad A Zouein; Yonggang Ma; Vincent Dive; Lisandra E de Castro Brás; Merry L Lindsey
Journal:  Int J Cardiol       Date:  2015-03-05       Impact factor: 4.164

7.  Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model.

Authors:  Sung-Whan Kim; Dong-Won Lee; Long-Hao Yu; Hong-Zhe Zhang; Chae Eun Kim; Jong-Min Kim; Tae-Ho Park; Kwang-Soo Cha; Su-Yeong Seo; Mee-Sook Roh; Keun-Cheol Lee; Jin-Sup Jung; Moo Hyun Kim
Journal:  Cardiovasc Res       Date:  2012-08-10       Impact factor: 10.787

8.  Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice.

Authors:  Ganesh V Halade; Yonggang Ma; Trevi A Ramirez; Jianhua Zhang; Qiuxia Dai; Julie G Hensler; Elizabeth F Lopez; Omid Ghasemi; Yu-Fang Jin; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-18       Impact factor: 4.733

Review 9.  Macrophage roles following myocardial infarction.

Authors:  Jessica M Lambert; Elizabeth F Lopez; Merry L Lindsey
Journal:  Int J Cardiol       Date:  2008-07-25       Impact factor: 4.164

10.  Guidelines for experimental models of myocardial ischemia and infarction.

Authors:  Merry L Lindsey; Roberto Bolli; John M Canty; Xiao-Jun Du; Nikolaos G Frangogiannis; Stefan Frantz; Robert G Gourdie; Jeffrey W Holmes; Steven P Jones; Robert A Kloner; David J Lefer; Ronglih Liao; Elizabeth Murphy; Peipei Ping; Karin Przyklenk; Fabio A Recchia; Lisa Schwartz Longacre; Crystal M Ripplinger; Jennifer E Van Eyk; Gerd Heusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-12       Impact factor: 4.733

View more
  11 in total

1.  Identifying the molecular and cellular signature of cardiac dilation following myocardial infarction.

Authors:  Merry L Lindsey; Yonggang Ma; Elizabeth R Flynn; Michael D Winniford; Michael E Hall; Kristine Y DeLeon-Pennell
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-20       Impact factor: 5.187

2.  The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction.

Authors:  Amanda R Kaminski; Edwin T Moore; Michael J Daseke; Fritz M Valerio; Elizabeth R Flynn; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-21       Impact factor: 4.733

3.  CD8+ T-cells negatively regulate inflammation post-myocardial infarction.

Authors:  Daria V Ilatovskaya; Cooper Pitts; Joshua Clayton; Mark Domondon; Miguel Troncoso; Sarah Pippin; Kristine Y DeLeon-Pennell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-19       Impact factor: 4.733

4.  Chronic Porphyromonas gingivalis lipopolysaccharide induces adverse myocardial infarction wound healing through activation of CD8+ T cells.

Authors:  Yusra Zaidi; Alexa Corker; Valeriia Y Vasileva; Kimberly Oviedo; Connor Graham; Kyrie Wilson; John Martino; Miguel Troncoso; Philip Broughton; Daria V Ilatovskaya; Merry L Lindsey; Kristine Y DeLeon-Pennell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-01       Impact factor: 5.125

Review 5.  Guidelines for in vivo mouse models of myocardial infarction.

Authors:  Merry L Lindsey; Keith R Brunt; Jonathan A Kirk; Petra Kleinbongard; John W Calvert; Lisandra E de Castro Brás; Kristine Y DeLeon-Pennell; Dominic P Del Re; Nikolaos G Frangogiannis; Stefan Frantz; Richard J Gumina; Ganesh V Halade; Steven P Jones; Rebecca H Ritchie; Francis G Spinale; Edward B Thorp; Crystal M Ripplinger; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-08       Impact factor: 5.125

6.  Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality.

Authors:  Merry L Lindsey; Mira Jung; Andriy Yabluchanskiy; Presley L Cannon; Rugmani Padmanabhan Iyer; Elizabeth R Flynn; Kristine Y DeLeon-Pennell; Fritz M Valerio; Courtney L Harrison; Crystal M Ripplinger; Michael E Hall; Yonggang Ma
Journal:  Cardiovasc Res       Date:  2019-02-01       Impact factor: 10.787

7.  Regenerative cross talk between cardiac cells and macrophages.

Authors:  Alexander J Whitehead; Adam J Engler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-03-26       Impact factor: 5.125

8.  LXR/RXR signaling and neutrophil phenotype following myocardial infarction classify sex differences in remodeling.

Authors:  Kristine Y DeLeon-Pennell; Alan J Mouton; Osasere K Ero; Yonggang Ma; Rugmani Padmanabhan Iyer; Elizabeth R Flynn; Ingrid Espinoza; Solomon K Musani; Ramachandran S Vasan; Michael E Hall; Ervin R Fox; Merry L Lindsey
Journal:  Basic Res Cardiol       Date:  2018-08-21       Impact factor: 17.165

9.  Reperfused vs. nonreperfused myocardial infarction: when to use which model.

Authors:  Merry L Lindsey; Lisandra E de Castro Brás; Kristine Y DeLeon-Pennell; Nikolaos G Frangogiannis; Ganesh V Halade; Caitlin C O'Meara; Francis G Spinale; Zamaneh Kassiri; Jonathan A Kirk; Petra Kleinbongard; Crystal M Ripplinger; Keith R Brunt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-06-11       Impact factor: 5.125

10.  Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome.

Authors:  D Kent Arrell; Christian S Rosenow; Satsuki Yamada; Atta Behfar; Andre Terzic
Journal:  NPJ Regen Med       Date:  2020-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.